A high dose of the investigational gene therapy AAV-GAD, which delivers the glutamic acid decarboxylase ( GAD) gene to the ...
Both these conditions are rising globally, at a rapid rate, and have a deep and profound impact on those diagnosed.
Since 1997, with the discovery of the Parkinson's disease-causing Ala53Thr variant in SNCA, the gene that encodes α-synuclein,1 our understanding of this common neurodegenerative disease has ...
Knowledge on the genetic basis of Parkinson's disease has grown tremendously since the discovery of the first monogenic form, ...
Broadcaster John Stapleton has revealed his diagnosis with Parkinson’s disease.The 78-year-old, who has presented on ...
Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Hearing loss was linked with higher Parkinson's ...
Neurodegenerative disorders such as Alzheimer's and Parkinson's diseases pose significant health challenges due to neuron ...
Vyalev (foscarbidopa and foslevodopa) as the first and only subcutaneous 24-hour infusion of levodopa-based therapy for motor ...
Global Pupillometer Market was valued at approximately USD 423.97 million in 2023, is projected to expand at a compound annual growth rate (CAGR) of 6.45% from 2024 to 2032. Read the Market Summary ...
The disruption of abnormal activity in the gut microbiome may increase our risk for neurological disease, research suggests.